Aileron Therapeutics - 48 Year Dividend History | ALRN

Historical dividend payout and yield for Aileron Therapeutics (ALRN) since 1971. The current TTM dividend payout for Aileron Therapeutics (ALRN) as of April 18, 2019 is $0.00. The current dividend yield for Aileron Therapeutics as of April 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.025B $0.000B
Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in developing and commercializing a novel class of therapeutics primarily in the United States. The companys lead product includes ALRN-6924, targets the tumor suppressor protein p53 for the treatment of a range of cancers which are in clinical stage. Aileron Therapeutics, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.312B 12.32
Gilead Sciences (GILD) United States $80.293B 10.22
Bio-Techne Corp (TECH) United States $7.144B 48.13